Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Acquisitions (2009 - 2014)

Updated

Savara's Acquisitions came in at -$3.44 million for FY2017.

Analysis

Savara (SVRA) Acquisitions (2009 - 2014) Analysis & Trends

  • The FY2017 figure represents the lowest annual Acquisitions since FY2014.
  • Per Business Quant, earlier years put Acquisitions at -$3.53 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -17.15 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.59 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Savara 1.09 Bn 407.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -3.53 Mn
Mar 31, 2013 32,395.00
Mar 31, 2012 32,395.00
Mar 31, 2011 32,395.00
Mar 31, 2010 32,395.00
Mar 31, 2009 32,395.00
API Access

Savara Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=SVRA&period=max&api_key=YOUR_API_KEY